...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR MEETING

It inform me that the company is not presenting this week but subject to planning they may present at the June meeting

Share
New Message
Please login to post a reply